IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies
- PMID: 17003362
- DOI: 10.2337/db06-0600
IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies
Abstract
Several lines of evidence indicate a causal role of the cytokine interleukin (IL)-6 in the development of type 2 diabetes in humans. Two common polymorphisms in the promoter of the IL-6 encoding gene IL6, -174G>C (rs1800795) and -573G>C (rs1800796), have been investigated for association with type 2 diabetes in numerous studies but with results that have been largely equivocal. To clarify the relationship between the two IL6 variants and type 2 diabetes, we analyzed individual data on >20,000 participants from 21 published and unpublished studies. Collected data represent eight different countries, making this the largest association analysis for type 2 diabetes reported to date. The GC and CC genotypes of IL6 -174G>C were associated with a decreased risk of type 2 diabetes (odds ratio 0.91, P = 0.037), corresponding to a risk modification of nearly 9%. No evidence for association was found between IL6 -573G>C and type 2 diabetes. The observed association of the IL6 -174 C-allele with a reduced risk of type 2 diabetes provides further evidence for the hypothesis that immune mediators are causally related to type 2 diabetes; however, because the association is borderline significant, additional data are still needed to confirm this finding.
Similar articles
-
A common functional variant on the pro-inflammatory Interleukin-6 gene may modify the association between long-term PM10 exposure and diabetes.Environ Health. 2016 Feb 24;15:39. doi: 10.1186/s12940-016-0120-5. Environ Health. 2016. PMID: 26911440 Free PMC article.
-
Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis.Hum Mol Genet. 2006 Jun 1;15(11):1914-20. doi: 10.1093/hmg/ddl113. Epub 2006 Apr 27. Hum Mol Genet. 2006. PMID: 16644865
-
Association between IL6 polymorphism and risk of cerebral infarction.Genet Mol Res. 2015 Dec 9;14(4):16438-43. doi: 10.4238/2015.December.9.14. Genet Mol Res. 2015. PMID: 26662441
-
Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index.Ann Med. 2009;41(2):128-38. doi: 10.1080/07853890802337037. Ann Med. 2009. PMID: 18752089 Free PMC article.
-
Association between -174G>C polymorphism in the IL-6 promoter region and the risk of obesity: A meta-analysis.Medicine (Baltimore). 2018 Aug;97(33):e11773. doi: 10.1097/MD.0000000000011773. Medicine (Baltimore). 2018. PMID: 30113463 Free PMC article. Review.
Cited by
-
Interleukin-6 (IL-6)-597 A/G (rs1800797) & -174 G/C (rs1800795) gene polymorphisms in type 2 diabetes.Indian J Med Res. 2014 Jul;140(1):60-8. Indian J Med Res. 2014. PMID: 25222779 Free PMC article.
-
Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus.World J Diabetes. 2014 Aug 15;5(4):493-504. doi: 10.4239/wjd.v5.i4.493. World J Diabetes. 2014. PMID: 25126395 Free PMC article. Review.
-
Association between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humans.PLoS One. 2011;6(9):e24719. doi: 10.1371/journal.pone.0024719. Epub 2011 Sep 14. PLoS One. 2011. PMID: 21935443 Free PMC article.
-
Systematic Analysis of Integrated Gene Functional Network of Four Chronic Stress-related Lifestyle Disorders.Genome Integr. 2015 Apr 28;6:1. doi: 10.4103/2041-9414.155952. eCollection 2015. Genome Integr. 2015. PMID: 27330735 Free PMC article.
-
Innate immunity, insulin resistance and type 2 diabetes.Diabetologia. 2012 Feb;55(2):273-8. doi: 10.1007/s00125-011-2387-y. Epub 2011 Nov 30. Diabetologia. 2012. PMID: 22124608
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
